Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059781/0672 | |
| Pages: | 5 |
| | Recorded: | 03/02/2022 | | |
| Attorney Dkt #: | 11450720US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17602880
|
Filing Dt:
|
10/11/2021
|
|
Publication #:
|
|
Pub Dt:
|
05/26/2022
| | | | |
|
Title:
|
USE OF SK2 INHIBITORS IN COMBINATION WITH IMMUNE CHECKPOINT BLOCKADE THERAPY FOR THE TREATMENT OF CANCER
|
|
|
Assignees
|
|
|
|
|
| 101, RUE DE TOLBIAC |
| PARIS, FRANCE 75013 |
|
|
|
|
|
| 118 ROUTE DE NARBONNE |
| TOULOUSE, FRANCE 31400 |
|
|
|
|
|
| 2, RUE VIGUERIE HÔTEL-DIEU PONT NEUF |
| TOULOUSE, FRANCE 31300 |
|
|
Correspondence name and address
|
| |
WC&F IP
|
| |
11491 SUNSET HILLS ROAD
|
| |
SUITE 340
|
| |
RESTON, VA 20190
|
Search Results as of:
05/09/2024 04:34 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
